STAT3 and Hepatic fibrosis: Although the antifibrotic activity of lycorine has been investigated in experimental models like bleomycin-induced pulmonary fibrosis [18], as well as several experimentally-induced cardiac dysfunctions [19,20,21], there is a paucity of information regarding the antifibrotic activity of lycorine against experimentally-induced hepatic fibrosis with respect to STAT3 activity.